Patients from which these lines were derived were diagnosed with disabling degrees of schizophrenia with onset in early adolescence; informed consent was obtained and all patients and their guardians consented by a child psychiatrist (RLF) under an approved protocol of Case Western School of Medicine, blinded as to subsequent line designations, and no study investigators had access to patient identifiers.
